No Data
No Data
Nexalin Technology Announces Results From Trial Using Its DIFS Technology
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
Express News | EXCLUSIVE: Nexalin Tells Benzinga New Study Shows Co's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory And Cognitive Function In Alzheimer's Patients
Nexalin Technology Analyst Ratings
Maxim Group Initiates Nexalin Technology(NXL.US) With Buy Rating, Announces Target Price $3
Nexalin Technology Initiated With a Buy at Maxim
No Data
No Data